Works by Oster, Yonatan


Results: 20
    1
    2
    3
    4
    5
    6
    7

    Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living With Human Immunodeficiency Virus: Evaluation of Clinical and Microbiome Parameters.

    Published in:
    Journal of Infectious Diseases, 2024, v. 230, n. 2, p. 411, doi. 10.1093/infdis/jiae167
    By:
    • Ziv, Omer Bar;
    • Cahn, Avivit;
    • Jansen, Tallulah;
    • Istomin, Valery;
    • Kedem, Eynat;
    • Olshtain-Pops, Karen;
    • Israel, Sarah;
    • Oster, Yonatan;
    • Orenbuch-Harroch, Efrat;
    • Korem, Maya;
    • Strahilevitz, Jacob;
    • Levy, Itzchak;
    • Valdés-Mas, Rafael;
    • Ivanova, Valeria;
    • Elinav, Eran;
    • Shahar, Eduardo;
    • Elinav, Hila
    Publication type:
    Article
    8
    9
    10

    Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.

    Published in:
    Infectious Diseases & Therapy, 2025, v. 14, n. 1, p. 167, doi. 10.1007/s40121-024-01089-9
    By:
    • Azuly, Hovav;
    • Shafat, Tali;
    • Grupel, Daniel;
    • Porges, Tzvika;
    • Abuhasira, Ran;
    • Belkin, Ana;
    • Deri, Ofir;
    • Oster, Yonatan;
    • Zahran, Shadi;
    • Horwitz, Ehud;
    • Horowitz, Netanel A.;
    • Khatib, Hazim;
    • Batista, Marjorie Vieira;
    • Cortez, Anita Cassoli;
    • Brosh-Nissimov, Tal;
    • Segman, Yafit;
    • Ishay, Linor;
    • Cohen, Regev;
    • Atamna, Alaa;
    • Spallone, Amy
    Publication type:
    Article
    11

    An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6997
    By:
    • Shafat, Tali;
    • Grupel, Daniel;
    • Porges, Tzvika;
    • Abuhasira, Ran;
    • Belkin, Ana;
    • Deri, Ofir;
    • Oster, Yonatan;
    • Zahran, Shadi;
    • Horwitz, Ehud;
    • Horowitz, Netanel A.;
    • Khatib, Hazim;
    • Batista, Marjorie Vieira;
    • Cortez, Anita Cassoli;
    • Brosh‐Nissimov, Tal;
    • Segman, Yafit;
    • Ishay, Linor;
    • Cohen, Regev;
    • Atamna, Alaa;
    • Spallone, Amy;
    • Chemaly, Roy F.
    Publication type:
    Article
    12
    13

    Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up.

    Published in:
    Journal of Nephrology (JNonline), 2022, v. 35, n. 1, p. 153, doi. 10.1007/s40620-021-01210-y
    By:
    • Ben-Dov, Iddo Z.;
    • Oster, Yonatan;
    • Tzukert, Keren;
    • Alster, Talia;
    • Bader, Raneem;
    • Israeli, Ruth;
    • Asayag, Haya;
    • Aharon, Michal;
    • Burstein, Ido;
    • Pri-Chen, Hadas;
    • Imam, Ashraf;
    • Abel, Roy;
    • Mor-Yosef Levi, Irit;
    • Khalaileh, Abed;
    • Oiknine-Djian, Esther;
    • Bloch, Aharon;
    • Wolf, Dana G.;
    • Dranitzki Elhalel, Michal
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20